Max F. Madu

428 total citations
21 papers, 256 citations indexed

About

Max F. Madu is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Max F. Madu has authored 21 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Max F. Madu's work include Cutaneous Melanoma Detection and Management (16 papers), Melanoma and MAPK Pathways (11 papers) and CAR-T cell therapy research (4 papers). Max F. Madu is often cited by papers focused on Cutaneous Melanoma Detection and Management (16 papers), Melanoma and MAPK Pathways (11 papers) and CAR-T cell therapy research (4 papers). Max F. Madu collaborates with scholars based in Netherlands, United States and Australia. Max F. Madu's co-authors include Alexander C. J. van Akkooi, Michel W.J.M. Wouters, Jos A. van der Hage, Katarzyna Jóźwiak, W. Martin C. Klop, Bernies van der Hiel, Bart A. van de Wiel, Christian U. Blank, Viola Franke and Elisa A. Rozeman and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and British journal of surgery.

In The Last Decade

Max F. Madu

20 papers receiving 254 citations

Peers

Countries citing papers authored by Max F. Madu

Since Specialization

Citations

This map shows the geographic impact of Max F. Madu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max F. Madu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max F. Madu more than expected).

Fields of papers citing papers by Max F. Madu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max F. Madu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max F. Madu. The network helps show where Max F. Madu may publish in the future.

Co-authorship network of co-authors of Max F. Madu

This figure shows the co-authorship network connecting the top 25 collaborators of Max F. Madu. A scholar is included among the top collaborators of Max F. Madu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max F. Madu. Max F. Madu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Near-Infrared Fluorescence with Indocyanine Green to Assess Bone Perfusion: A Systematic Review 2022 ·Life ·(unknown), Max F. Madu, Henri A. H. Winters, Daniël M. de Bruin, Joost R. van der Vorst, (unknown)	6
2	Reversal of pre-existing NGFR-driven tumor and immune therapy resistance 2020 ·Nature Communications ·Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman, Maarten A. Ligtenberg, (unknown), Beaunelle de Bruijn, Dennie T. Frederick, Juliana C.N. Kenski, Mara Parren, (unknown), Max F. Madu, Elisa A. Rozeman, Ji‐Ying Song, Hugo M. Horlings, Christian U. Blank, Alexander C. J. van Akkooi, Keith T. Flaherty, Genevieve M. Boland, Daniel S. Peeper	66
3	Challenges in sentinel node pathology in the era of adjuvant treatment 2020 ·Journal of Surgical Oncology ·Viola Franke, Max F. Madu, Carolien Bierman, W. Martin C. Klop, Winan J. van Houdt, Michel W.J.M. Wouters, Bart A. van de Wiel, Alexander C. J. van Akkooi	4
4	External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment? 2019 ·Melanoma Research ·Max F. Madu, Viola Franke, Bart A. van de Wiel, W. Martin C. Klop, Katarzyna Jóźwiak, Winan J. van Houdt, Michel W.J.M. Wouters, Alexander C. J. van Akkooi	13
5	Parotidectomy in patients with head and neck cutaneous melanoma with cervical lymph node involvement 2019 ·Head & Neck ·(unknown), Martinus M. van Veen, Max F. Madu, Alexander C. J. van Akkooi, Wouter V. Vogel, Alfons J. M. Balm, W. Martin C. Klop	6
6	Challenges in sentinel node (SN) pathology in the era of adjuvant treatment: The risk of over and undertreatment stress the need for expert pathology review. 2019 ·Journal of Clinical Oncology ·Viola Franke, Max F. Madu, Carolien Bierman, W. Martin C. Klop, Winan J. van Houdt, Michel W.J.M. Wouters, Bart A. van de Wiel, Alexander Christopher Jonathan Van Akkooi	1
7	External validation of the 8th Edition Melanoma Staging System of the American Joint Committee on Cancer (AJCC): Effect of adding EORTC sentinel node (SN) tumor burden criteria on prognostic accuracy in stage III. 2018 ·Journal of Clinical Oncology ·Max F. Madu, Viola Franke, B. van de Wiel, W. Martin C. Klop, Katarzyna Jóźwiak, Michel W.J.M. Wouters, Alexander Christopher Jonathan Van Akkooi	9
8	Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience 2017 ·European Journal of Surgical Oncology ·(unknown), Max F. Madu, Margot Tesselaar, Cornelis Verhoef, Dirk J. Grünhagen, Alexander C. J. van Akkooi	11
9	Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients 2017 ·Annals of Surgical Oncology ·Max F. Madu, Marion M. Deken, Jos A. van der Hage, Katarzyna Jóźwiak, Michel W.J.M. Wouters, Alexander C. J. van Akkooi	23
10	Isolated limb perfusion for melanoma is safe and effective in elderly patients 2017 ·European Journal of Cancer ·Max F. Madu, Donald W. Marion, Jos A. van der Hage, Katarzyna Jóźwiak, Michel W.J.M. Wouters, Alexander C. J. van Akkooi	4
11	Concurrent Merkel Cell Carcinoma and Melanoma in Individual Patients Presents a Treatment Challenge: A Case Series 2017 ·Max F. Madu, (unknown), B. van de Wiel, Margot Tesselaar, Alexander C. J. van Akkooi	0
12	PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study 2017 ·Melanoma Research ·Max F. Madu, (unknown), Michel W.J.M. Wouters, Bernies van der Hiel, Jos A. van der Hage, Alexander C. J. van Akkooi	15
13	PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study 2017 ·European Journal of Cancer ·Max F. Madu, (unknown), Miel Wouters, Bernies van der Hiel, Jos A. van der Hage, Alexander C. J. van Akkooi	3
14	Downsizing of locally advanced stage III (bulky) BRAF V600E/K melanoma with combination targeted therapy to achieve R0 resection 2017 ·European Journal of Cancer ·J.B.A.G. Haanen, (unknown), (unknown), Henk Mallo, S. Adriaansz, Sylvia ter Meulen, Max F. Madu, Loes M. Pronk, Bernies van der Hiel, B. van de Wiel, Daniel S. Peeper, Alexander C. J. van Akkooi	3
15	Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin 2017 ·British journal of surgery ·D. Verver, Max F. Madu, (unknown), (unknown), Johannes H. W. de Wilt, Han J. Bonenkamp, Dirk J. Grünhagen, Alexander C. J. van Akkooi, Cornelis Verhoef, Barbara L. van Leeuwen	13
16	Sentinel node biopsy in melanoma: Current controversies addressed 2016 ·European Journal of Surgical Oncology ·Max F. Madu, Michel W.J.M. Wouters, Alexander C. J. van Akkooi	44
17	Clinical Prognostic Markers in Stage IIIB Melanoma 2016 ·Annals of Surgical Oncology ·Max F. Madu, Michel W.J.M. Wouters, W. Martin C. Klop, Bernies van der Hiel, Bart A. van de Wiel, Katarzyna Jóźwiak, Jos A. van der Hage, Alexander C. J. van Akkooi	4
18	Neoadjuvant Cytoreductive Treatment of Regionally Advanced Melanoma With BRAF/MEK Inhibition: Study Protocol of the REDUCTOR (Cytoreductive Treatment of Dabrafenib Combined With Trametinib to Allow Complete Surgical Resection in Patients With BRAF Mutated, Prior Unresectable Stage III or IV Melanoma) Trial 2016 ·Max F. Madu, Elisa A. Rozeman, Jos A. van der Hage, Michel W.J.M. Wouters, W. Martin C. Klop, (unknown), Christian U. Blank, John B.A.G. Haanen, Alexander C. J. van Akkooi	5
19	Blue dye can be safely omitted in most sentinel node procedures for melanoma 2016 ·Melanoma Research ·Iris M. C. van der Ploeg, Max F. Madu, Jos A. van der Hage, Michel W.J.M. Wouters, W. Martin C. Klop, Bernies van der Hiel, Bart A. van de Wiel, Alexander C. J. van Akkooi	11
20	Rapamycin Induces Heme Oxygenase-1 in Liver but Inhibits Bile Flow Recovery after Ischemia 2011 ·Journal of Surgical Research ·(unknown), (unknown), Max F. Madu, (unknown), (unknown), (unknown), Vincent B. Nieuwenhuijs, Robert J. Porte, Robert T. A. Padbury, Greg J. Barritt	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact